Home/ Supplements/ Niacin/ A-HD 250 mg

A-HD 250 mg

product on market Capsule BPI Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 33% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

✨ AI-generated · Qwen 3.6 · methodology

Niacin is well-documented for supporting metabolic function and cardiovascular health. Evidence for the proprietary phytochemical and A-HD blends is limited due to the lack of specific dosage transparency. Overall, these ingredients are generally recognized as safe, though research on the combined blend's efficacy is minimal.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for A-HD 250 mg
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Capsule(s)
Serving Size
Other Combinations
Product Type
33%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

25 mg (125% DV)
1.8× RDA — within safe limits 196 studies (A:5, B:63)
A-HD Proprietary Blend
250 mg
Standard Phytochemical Complex Blend
30 mg

Other Ingredients

Gelatin Microcrystalline Cellulose Magnesium Stearate Silicon Dioxide Hypromellose Polyvinylpyrrolidone Maltodextrin Stearic Acid Capsicum annuum FD&C Blue No. 1 Titanium Dioxide
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Suggested Usage: Take one (1) capsule daily, (in the morning) at the same time each day, or as directed by a qualified healthcare practitioner. Must be taken on a full stomach. For best results take four to eight (4-8) consecutive weeks (1-2 Cycles). Do not take this product longer than 8 consecutive weeks. A four (4) week break between cycles is recommended.

Warnings & Precautions

Keep this product and all supplements out of the reach of children.

Do not take if you are pregnant, lactating or trying to become pregnant.

Do not exceed recommended dose. Do not take for more than 8 consecutive weeks.

Get the consent of a licensed physician before using this product, especially if you are taking medication or have a medical condition.

Please read entire label before use.

Warnings: Not intended for use by persons under age 18.

This product should not be taken by women.

Additional Information

Androgenic/Estrogenic Modulator*

Rev. 01-002-AHD001 07/11

Testosterone Booster*

This product has been tested at a third-party independent lab.

Metadata

Product Details

UPC / SKU8 51780 00223 0
DSLD Entry Date2011-11-25
Product TypeOther Combinations
FormCapsule
BrandBPI
DSLD ID2071
Data Updated2026-04-11
Research

Research Evidence

241
Research Sources
55
Avg Quality
113
Meta Analysis
75
Systematic Review
32
Rct
11
Clinical Trial
3
Other
3
Regulatory Source
1
Cochrane Review
1
Narrative Review
1
Openfda Safety
A Niacin for primary and secondary prevention of cardiovascular events
Meta Analysis The Cochrane database of systematic reviews 2017 PubMed DOI
A Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases
Meta Analysis BMJ (Clinical research ed.) 2013 PubMed DOI
A Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117,411 patients
Meta Analysis BMJ (Clinical research ed.) 2014 PubMed DOI
A A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk
Meta Analysis Nature medicine 2024 PubMed DOI
A Meta-analysis and imputation refines the association of 15q25 with smoking quantity
Meta Analysis Nature genetics 2010 PubMed DOI
A Genome-wide meta-analyses identify multiple loci associated with smoking behavior
Meta Analysis Nature genetics 2010 PubMed DOI
A Antidepressants for smoking cessation
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
A Topical azelaic acid, salicylic acid, nicotinamide, sulphur, zinc and fruit acid (alpha-hydroxy acid) for acne
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
B Assessment of the Role of Niacin in Managing Cardiovascular Disease Outcomes: A Systematic Review and Meta-analysis
Meta Analysis JAMA network open 2019 PubMed DOI
B Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions: A Systematic Review and Meta-analysis
Meta Analysis JAMA 2016 PubMed DOI
View all evidence for Niacin →
Compare

Similar Products

Serotone 5HTP 50 mg
Higher Nature · Capsule
100
Serotone 5HTP 100 mg
Higher Nature · Capsule
100
ChromeMate
NOW · Capsule
100
ChromeMate 200 mcg
Protocol For Life Balance · Capsule
100
Non Flush Niacin
Highland Laboratories · Capsule
100
View all Niacin products →
Niacin research Best Niacin All Niacin products More from BPI View on NIH DSLD →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.